Download User Guide

16778 results returned.
Page   of  1049

A 02843 – New York
Introduced: 2019   Status: Inactive / Dead  
Requires Medicaid managed care, and Child Health Plus plans to adopt the procedural protections of the Preferred Drug Program, including “prescriber prevails,” for all drugs.

A 02859 (see companion bill S 03295) – New York
Introduced: 2019   Status: Inactive / Dead  
Establishes the transparency in health care fees act requiring health care providers to submit bills to patients prior to performing services.

A 02910 – New York
Introduced: 2019   Status: Inactive / Dead  
Creates the health insurance guaranty fund.

A 02969 (see companion bill S 02849) – New York
Introduced: 2019   Status: Inactive / Dead  
AN ACT to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year to allow formulary changes mid-year if a generic equivalent is released.

A 02970 (see companion bill S 01705) – New York
Introduced: 2019   Status: Inactive / Dead  
Implements the pharmacy benefit manager transparency act requiring disclosure and publishing of reports relating to pharmacy benefit managers.

A 02975 – New York
Introduced: 2019   Status: Inactive / Dead  
Directs health insurers to provide enrollees the option to assign the payment of emergency services benefits directly to an out of network health care provider.

A 02983 – New York
Introduced: 2019   Status: Inactive / Dead  
Relates to certain prohibitions in contracts or agreements by health maintenance organizations; prohibits clauses which entitle reimbursement at the lowest price or rate; prohibits contracts which restrict referral of patients based solely upon a health …

A 03038 (see companion bill S 02847) – New York
Introduced: 2019   Status: Inactive / Dead  
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; amends provisions relating to prescription drug formulary changes and pre-authorization for certain health care services.

A 03043 (see companion bill S 04463) – New York
Introduced: 2019   Status: Inactive / Dead  
Relates to the purchase of prescription drugs.

A 03048 – New York
Introduced: 2019   Status: Inactive / Dead  
Includes nurse practioners as a provider of services for purposes of collaborative drug therapy management and makes the authorization for pharmacists to perform such management permanent.

A 03218 – New York
Introduced: 2019   Status: Inactive / Dead  
Provides that health maintenance organizations shall provide market access to diagnostic laboratories.

A 03273 – New York
Introduced: 2015   Status: Inactive / Dead  
DRUG TIERS: would require the Superintendent of the Insurance Department to deny policies that impose drug tiers that are based on expense or disease. It would also require the superintendent to deny polices that charge …

A 03829 (see companion bill S 01798 – New York
Introduced: 2019   Status: Inactive / Dead  
Prohibits price gouging by manufacturers of prescription drugs.

A 03836 (see companion bill S 01816) – New York
Introduced: 2019   Status: Inactive / Dead  
Directs the commissioner of health to promote home care’s integration into the state’s health continuum strategy to address public health priorities in disease prevention, intervention, population health improvement, associated health care cost reduction and research.

A 03928 (see companion bill S 01323) – New York
Introduced: 2019   Status: Inactive / Dead  
Relates to the reimbursement of out-of-network providers of clinical laboratory services by organizations providing or offering comprehensive health services plans.

A 04103 – New York
Introduced: 2019   Status: Inactive / Dead  
Directs a health maintenance organization which denies claim due to absence of medical necessity to inform insured as to preferred alternative treatment, or provide the insured with a statement as to the past ineffectiveness of …

16778 results returned.
Page   of  1049

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Go to Top